CTRI/2026/01/100134RecruitingPhase 2/3
A Randomized Sham-controlled Trial to see the Impact of Craniosacral therapy on Stress-Coping and Performance in Shooters
Jaipur National University1 site in 1 country40 target enrollmentStarted: January 14, 2026Last updated:
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Recruiting
- Sponsor
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- CSAI-2
Study Overview
Brief Summary
This randomized sham-controlled trial aims to evaluate the effect of Craniosacral Therapy on stress coping and performance in competitive shooters. Forty athletes will be randomly allocated to receive either Craniosacral Therapy or Sham Therapy for six weeks. Stress levels will be assessed using the Competitive State Anxiety Inventory-2, and performance will be evaluated using shooting accuracy scores. The study aims to determine whether Craniosacral Therapy is an effective non-invasive intervention for improving stress management and performance in shooters.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- Participant and Outcome Assessor Blinded
Eligibility Criteria
- Ages
- 15.00 Year(s) to 26.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Athletes Specializing in Shooting at professional level Athletes engaging in high intensity sports with increased competition Anxiety.
Exclusion Criteria
- •Athletes undertaking any medications Athletes who engage in any other sports Athletes undergoing other physical therapy interventions Athletes participating in sports as recreational Activity.
Outcomes
Primary Outcomes
CSAI-2
Time Frame: 6 weeks
Secondary Outcomes
- Shooting Accuracy Score(6 weeks)
Investigators
Nishita Ayla Sona
Jaipur National University
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Efficacy of Craniosacral Therapy in Patients With GonarthrosisKnee OsteoarthritisNCT07372534Ankara Yildirim Beyazıt University21
Recruiting
Not Applicable
Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and SafetyNCT07296497Xiangya Hospital of Central South University104
Recruiting
Phase 3
Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)NCT07262645Danyang Huichuang Medical Equipment Co., Ltd.320
Completed
Not Applicable
Sleep Efficacy Randomized Evaluation of a Novel Digital Therapeutic for InsomniaInsomniaNCT07295431BELL Therapeutics Inc.116
Not yet recruiting
Not Applicable
Lacrima VR for Dry Eye Disease and Meibomian Gland DysfunctionDry EyeNCT07415330Demaod Ltd20